General protein and nucleic acid binding (N/A)

General protein and nucleic acid binding is a broad functional classification used in bioinformatics to describe the ability of a molecule to interact non-covalently with proteins or nucleic acids like DNA and RNA. This term does not refer to a specific protein, receptor, or enzyme, but rather a fundamental biochemical property shared by a vast majority of the proteome (Gene Ontology Consortium, 2021). Because it encompasses thousands of distinct molecular entities with diverse structures and roles, it is not considered a valid therapeutic target for drug discovery. Instead, pharmacological intervention focuses on specific members of this category, such as specific transcription factors or RNA polymerases, to ensure selectivity and safety (NCBI, 2023). Targeting 'general binding' would result in ubiquitous cellular disruption and high toxicity due to the essential nature of these interactions in every biological process. Consequently, this entry is best understood as a Gene Ontology (GO) annotation rather than a discrete site for drug action. Biotech analysts should treat this as a functional category that requires further specification to identify a viable lead or target (UniProt, 2024).

Other names

Protein bindingNucleic acid bindingGO:0003676GO:0005515Polynucleotide binding

Not applicable as this is a broad functional category rather than a specific molecular target.